AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study

NCT03100123 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Pilot deemed not feasible by Steering Committee due to recruitment rate.

Conditions

Antiphospholipid Syndrome in Pregnancy
Pregnancy Loss

Interventions

DRUG: Aspirin 81 mg
DRUG: Low-molecular-weight heparin

Sponsor

Ottawa Hospital Research Institute